Enzymes

Enzymes(酶)

Enzymes are very efficient and specific catalyst proteins which react with 1 or few types of substrates in biochemical reactions and are responsible for bringing about almost all of the chemical reactions in living organisms. Enzymes speed up reactions by providing an alternative reaction pathway of lower activation energy. Without enzymes, reactions take place at a rate far too slow for the pace of metabolism which means that they speed up the chemical reactions in living things.

There are 2 types of enzymes, ones that help join specific molecules together to form new molecules & others that help break specific molecules apart into separate molecules. Enzymes play many important roles ouside the cell as well. One of the best examples of this is the digestive system. For instance, it is enzymes in your digestive system that break food down in your digestive system break food down into small molecules that can be absorbed by the body. Some enzymes in your digestive system break down starch, some proteins and others break down fats. The enzymes used to digest our food are extra-cellular since they are located outside our cells & enzymes inside our cells are intra-cellular enzymes. Enzymes are used in ALL chemical reactions in living things; this includes respiration, photosynthesis, movement growth, getting rid of toxic chemicals in the liver and so on. Enzymes are proteins that must have the correct structure to be active. They are very easily affected by heat, pH and heavy metal ions.

Ribonucleoprotein enzyme catalytic activity is located in the protein part but for some the catalytic activity is in the RNA part. A catalyst is any substance which makes a chemical reaction go faster, without itself being changed. A catalyst can be used over and over again in a chemical reaction and does not get used up.

Enzymes lower the amount of activation energy needed by binding to the reactants of the reaction they catalyze, thus speed up the reaction and can process millions of molecules per second. Enzymes are typically large proteins with high molecular weight that permit reactions to go at conditions that the body can tolerate.

Enzyme nomenclature is based on what the enzyme reacts with & how it reacts along with the ending ase.

Enzymes must get over the activation energy hurdle.

Enzymes change how a reaction will proceed which reduces the activation energy and makes it faster. The more we increase the enzyme concentration the faster the reaction rate for non-catalyzed reactions. Enzymes that are catalyzed reactions also increase reaction rate at higher level of concentration but up to a certain point called Vmax which means that the enzyme has reached its maximum point. The reaction is limited by both the concentrations of the enzyme and substrate. Enzymes as catalysts take part in reactions which provide an alternative reaction pathway. Enzymes do not undergo permanent changes and remain unchanged at the end of the reaction. They only change the rate of reaction, not the position of the equilibrium.Enzymes as catalysts are highly selective by only catalysing specific reactions due to the shapes of the enzyme’s molecule.

Enzymes contain a globular protein part called apoenzyme and a non-protein part named cofactor or prosthetic group or metal-ion-activator. Changes in temperature and pH have great influence on the intra- and intermolecular bonds that hold the protein part in their secondary and tertiary structures.

Examples of cofactors are 1. Prosthetic group that are permanently bound to the enzyme. 2. Activator group which are cations (positively charged metal ions) & temporarily bind to the active site of the enzyme. 3.Coenzymes, usually vitamins or made from vitamins which are not permanently bound to the enzyme molecule, but combine with the enzyme-substrate complex temporarily. Enzymes require the presence cofactors before their catalytic activity can be exerted. This entire active complex is referred to as the holoenzyme.

Without enzymes, our guts would take weeks to digest our food, our muscles, nerves and bones would not work properly and so on…

Main Enzyme category groups:

Oxidoreductases:
All enzymes that catalyse oxido-reductions belong in this class. The substrate oxidized is regarded as a hydrogen or electron donor. The classification is based on 'donor:acceptor oxidoreductase'. The common name is 'dehydrogenase', wherever this is possible; as an alternative, 'acceptor reductase' can be used. 'Oxidase' is used only where O2 is an acceptor. Classification is difficult in some cases, because of the lack of specificity towards the acceptor.

Transferases:
Transferases are enzymes that transfer a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme 'donor:acceptor grouptransferase'. The common names are normally formed as 'acceptor grouptransferase' or 'donor grouptransferase'. In many cases, the donor is a cofactor (coenzyme) that carries the group to be transferred. The aminotransferases constitute a special case.

Hydrolases:
These enzymes catalyse the hydrolysis of various bonds. Some of these enzymes pose problems because they have a very wide specificity, and it is not easy to decide if two preparations described by different authors are the same, or if they should be listed under different entries. While the systematic name always includes 'hydrolase', the common name is, in most cases, formed by the name of the substrate with the suffix -ase. It is understood that the name of the substrate with this suffix, and no other indicator, means a hydrolytic enzyme. It should be noted that peptidases have recommended names rather than common names.

Lyases:
Lyases are enzymes that cleave C-C, C-O, C-N and other bonds by means other than by hydrolysis or oxidation. They differ from other enzymes in that two (or more) substrates are involved in one reaction direction, but there is one compound fewer in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. The systematic name is formed according to 'substrate group-lyase'. In common names, expressions like decarboxylase, aldolase, etc. are used. 'Dehydratase' is used for those enzymes that eliminate water. In cases where the reverse reaction is the more important, or the only one to be demonstrated, 'synthase' may be used in the name.

Ligases:
Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. 'Ligase' is often used for the common name, but, in a few cases, 'synthase' or 'carboxylase' is used. 'Synthetase' may be used in place of 'synthase' for enzymes in this class.

研究方向

Enzymes 相关产品(1726)

  • GC65153 structure
    GC65153KGP94
    CAS: 1131456-28-4
    纯度: >99.00%

    KGP94 是一种特异的 cathepsin L 抑制剂,IC50为 189 nM。KGP94 抑制转移癌的运动性和侵袭性,对人类细胞的毒性低 (GI50=26.9µM)。

  • GC65157 structure
    GC65157Naphthol AS-BR
    CAS: 91-92-9
    纯度: >98.00%

    Naphthol AS-BR 是组织化学中,酸性和碱性磷酸酶的底物。

  • GC65260 structure
    GC65260EDP-305
    CAS: 1933507-63-1
    纯度: >96.00%

    EDP-305 是一种口服有效且选择性的 farnesoid X 受体 (FXR) 激动剂,其 EC50 值为 34 nM (CHO 细胞嵌合性 FXR) 和 8 nM (HEK 细胞全长 FXR)。EDP-305 显示出强大而持久的抗纤维化作用。EDP-305 可用于原发性胆道胆管炎 (PBC) 和非酒精性脂肪性肝炎 (NASH) 研究。

  • GC65271 structure
    GC65271p-Hydroxyphenethyl trans-ferulate
    CAS: 84873-15-4
    纯度: >99.00%

    p-Hydroxyphenethyl trans-ferulate 具有抗高血糖 (酵母α-葡萄糖苷酶,IC50 19.24 ± 1.73 µmol L-1),抗氧化,抗炎活性。p-Hydroxyphenethyl trans-ferulate 具有抗癌活性和血清素能活性。

  • GC65307 structure
    GC65307S130
    CAS: 1160852-22-1
    纯度: >99.00%

    S130 是一种高亲和力、选择性的半胱氨酸蛋白酶 ATG4B 的抑制剂, IC50 值为 3.24 µM。S130 可以抑制自噬通量。

  • GC65308 structure
    GC65308SHIP2-IN-1
    CAS: 2252247-80-4
    纯度: >99.00%

    SHIP2-IN-1 是一种有效的 SHIP2 抑制剂,IC50 值为 2 µM。SHIP2-IN-1 可使 GSK3β 的 Ser9 位点磷酸化,抑制 GSK3β 的活化。SHIP2-IN-1 可用于阿尔滋海默症的研究。

  • GC65394 structure
    GC653947-BIA
    CAS: 1313403-49-4
    纯度: >98.00%

    7-BIA 是一种受体型蛋白酪氨酸磷酸酶 D (PTPRD) 抑制剂,IC50 值约为 1-3 μM。

  • GC65432 structure
    GC65432LV-320
    CAS: 2449093-46-1
    纯度: >95.00%

    LV-320 是一种有效且非竞争性的 ATG4B 抑制剂,其 IC50 值为 24.5 μM,Kd 值为 16 μM。 LV-320 抑制 ATG4B 的酶促活性,阻断细胞自噬,并且在体内稳定,无毒且有活性。

  • GC65533 structure
    GC65533SHP394
    CAS: 2055757-40-7
    纯度: >99.00%

    SHP394 是一种有效的,具有口服活性的,变构的选择性SHP2 抑制剂,IC50 为 23 nM。

  • GC65542 structure
    GC65542NSC-87877 disodium
    CAS: 56932-43-5

    A potent inhibitor of SHP- 1 and SHP- 2

  • GC65547 structure
    GC65547(1S,2R)-Alicapistat
    CAS: 2221010-57-5
    纯度: >98.00%

    (1S,2R)-Alicapistat ((1S,2R)-ABT-957) 是一种具有口服活性的人钙激活中性蛋白酶 (calpains 1 和 2) 的选择性抑制剂,可能用于阿尔茨海默病 (AD) 的研究。 Alicapistat 可减轻羰基还原的代谢倾向,对 calpain 1 的 IC50 为 395 nM。

  • GC65549 structure
    GC65549Indisulam
    CAS: 165668-41-7
    纯度: >99.00% / >98.00%

    Indisulam是一种磺胺类抗肿瘤药物和分子胶降解剂,通过与CUL4-DCAF15 E3泛素连接酶结合诱导RNA结合基序蛋白39(RBM39)的蛋白酶体降解,同时抑制碳酸酐酶并阻滞细胞周期在G1期。

  • GC65612 structure
    GC65612Acetazolamide sodium
    CAS: 1424-27-7
    纯度: >99.50%

    An Analytical Reference Standard

  • GC65668 structure
    GC656685-Amino-8-hydroxyquinoline
    CAS: 13207-66-4

    5-氨基-8-羟基喹啉(5A8HQ)是一种潜在的抗癌候选药物,具有良好的蛋白酶体抑制活性

  • GC65938 structure
    GC65938Thrombin inhibitor 5
    CAS: 328108-09-4

    WAY-358871 is a bioactive compound.

  • GC65957 structure
    GC65957MMP13-IN-2
    CAS: 935759-55-0
    纯度: >99.00%

    MMP13-IN-2 是一种有效、选择性和口服活性的 MMP-13 抑制剂。MMP13-IN-2 对 MMP-13 具有优异的效价 (IC50=0.036 nM),对 MMP-1、3、7、8、9、14 和 TACE 的选择性(大于 1500 倍)。MMP13-IN-2 在体外具有阻止软骨释放胶原蛋白的能力。MMP13-IN-2 具有胶原酶相关疾病研究的潜力。

  • GC65998 structure
    GC65998Cathepsin C-IN-5
    CAS: 2825567-97-1
    纯度: >95.00%

    Cathepsin C-IN-5 (compound SF38) 是一种有效的、选择性的和具有口服活性的 组织蛋白酶 C 抑制剂,Cat C、Cat L、Cat S、Cat B、Cat K 的 IC50s 分别为 59.9 nM, 4.26 µM、>5 µM、>5 µM、>5 µM。Cathepsin C-IN-5 抑制骨髓和血液中的 Cat C 活性。Cathepsin C-IN-5 降低 NSP(中性粒细胞丝氨酸蛋白酶)的活化。Cathepsin C-IN-5 具有抗炎活性。

  • GC66029 structure
    GC66029hCAI/II-IN-6
    CAS: 694466-00-7
    纯度: >98.00%

    hCAI/II-IN-6 是一种具有口服活性的 human carbonic anhydrase (CA) 抑制剂。hCAI/II-IN-6 选择性地抑制 hCA II 和 hCA VII,对 hCA I,hCA II,hCA VII 和 hCA XII 的 Ki 值分别为 220,4.9,6.5 和 >50000 nM。hCAI/II-IN-6 在体内显示抗惊厥活性和抗最大电击 (MES) 活性。hCAI/II-IN-6 可以用于癫痫的研究。

  • GC66033 structure
    GC66033Casein kinase 1δ-IN-1
    CAS: 851871-94-8
    纯度: >99.00%

    Casein kinase 1δ-IN-1 (compound 822) 是酪蛋白激酶 1δ (CK1δ) 的抑制剂,抑制作用大于5%。Casein kinase 1δ-IN-1 可用于神经退行性疾病,如阿尔茨海默病的研究。

  • GC66360 structure
    GC66360Girentuximab
    CAS: 916138-87-9
    纯度: >99.00%

    Girentuximab (G250) 是一种嵌合单克隆抗体,可与碳酸酐酶 IX (CAIX) 结合,碳酸酐酶 IX 是一种在透明细胞肾细胞癌 (ccRCC) 中广泛表达的细胞表面糖蛋白。

  • GC67775 structure
    GC67775Casein kinase 1δ-IN-3
    CAS: 349438-77-3

    Casein kinase 1δ-IN-3 (Compound 23a) 是一种酪蛋白激酶 1δ (CK1d) 抑制剂,pIC50 为 6.5376 M。

  • GC67798 structure
    GC67798MLS-0437605
    CAS: 862975-18-6
    纯度: >98.00%

    MLS-0437605 是一种选择性双特异性磷酸酶 3 (DUSP3) 抑制剂,IC50 为 3.7 μM。MLS-0437605 对 DUSP3 的选择性比对 DUSP22 和其他蛋白酪氨酸磷酸酶 (PTP) 更具选择性。

  • GC67899 structure
    GC67899Aurora kinase inhibitor-8
    CAS: 2133001-88-2

    Aurora kinase inhibitor-8 是一种高选择性 Aurora 激酶的抑制剂。

  • GC67908 structure
    GC67908Calpain-2-IN-1
    CAS: 144231-85-6
    纯度: >98.00%

    Calpain-2-IN-1 (Formula 1A) 是一种 calpain-2 亚型特异性的抑制剂,对 calpain-1 和 calpain-2 的 Ki 分别为 181 nM 和 7.8 nM。Calpain-2-IN-1 可用于神经退行性疾病和其他突触功能疾病的研究。